JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 102 filers reported holding JOUNCE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,493,770 | +3.8% | 807,443 | -37.7% | 0.00% | – |
| Q4 2022 | $1,439,246 | -5.8% | 1,296,618 | +98.6% | 0.00% | – |
| Q3 2022 | $1,528,000 | -23.3% | 653,035 | -0.7% | 0.00% | – |
| Q2 2022 | $1,993,000 | -44.7% | 657,919 | +23.9% | 0.00% | – |
| Q1 2022 | $3,606,000 | -14.8% | 531,029 | +4.8% | 0.00% | – |
| Q4 2021 | $4,231,000 | +14.4% | 506,758 | +1.8% | 0.00% | – |
| Q3 2021 | $3,700,000 | +24.0% | 497,985 | +13.5% | 0.00% | – |
| Q2 2021 | $2,984,000 | -5.1% | 438,765 | +43.3% | 0.00% | – |
| Q1 2021 | $3,145,000 | +36.7% | 306,279 | -6.8% | 0.00% | – |
| Q4 2020 | $2,301,000 | -16.0% | 328,706 | -2.0% | 0.00% | – |
| Q3 2020 | $2,738,000 | +11.6% | 335,546 | -5.7% | 0.00% | – |
| Q2 2020 | $2,454,000 | +23.4% | 355,716 | -15.1% | 0.00% | – |
| Q1 2020 | $1,989,000 | -44.3% | 418,772 | +2.5% | 0.00% | – |
| Q4 2019 | $3,568,000 | +154.7% | 408,691 | -2.8% | 0.00% | – |
| Q3 2019 | $1,401,000 | -24.4% | 420,677 | +12.5% | 0.00% | – |
| Q2 2019 | $1,852,000 | +17.7% | 374,069 | +47.3% | 0.00% | – |
| Q1 2019 | $1,574,000 | +93.8% | 253,895 | +5.4% | 0.00% | – |
| Q4 2018 | $812,000 | -52.2% | 240,879 | -7.7% | 0.00% | – |
| Q3 2018 | $1,699,000 | -13.3% | 260,989 | +2.1% | 0.00% | – |
| Q2 2018 | $1,959,000 | -65.4% | 255,677 | +0.9% | 0.00% | – |
| Q1 2018 | $5,661,000 | +143.6% | 253,379 | +39.1% | 0.00% | – |
| Q4 2017 | $2,324,000 | -3.1% | 182,160 | +18.3% | 0.00% | – |
| Q3 2017 | $2,398,000 | +70.2% | 154,038 | +53.7% | 0.00% | – |
| Q2 2017 | $1,409,000 | +40.9% | 100,233 | +120.6% | 0.00% | – |
| Q1 2017 | $1,000,000 | – | 45,430 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 2,697,829 | $20,045,000 | 88.84% |
| TRV GP III, LLC | 3,048,780 | $22,652,000 | 4.30% |
| Logos Global Management LP | 2,000,000 | $14,860,000 | 1.07% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,559 | $1,550,000 | 0.88% |
| PFM Health Sciences, LP | 3,848,822 | $28,597,000 | 0.84% |
| Yorktown Management & Research Co Inc | 113,200 | $841,000 | 0.63% |
| Moloney Securities Asset Management, LLC | 282,250 | $2,097,000 | 0.38% |
| PATHWAY CAPITAL MANAGEMENT, LP | 84,763 | $630,000 | 0.30% |
| Sofinnova Investments, Inc. | 637,347 | $4,735,000 | 0.28% |
| Omega Fund Management, LLC | 275,513 | $2,047,000 | 0.23% |